IRTC

iRhythm Holdings, Inc.

Nasdaq · Surgical & Medical Instruments & Apparatus · CIK 0001388658
$113.65 +0.87% $3.7B
Insider Selling Cluster (2 insiders)High Impact Filing (8/10)26 New Institutional Positions19 Institutional Exits
Vol
Market Cap$3.7B
Cap SizeMid Cap
Analyst ConsensusStrong Buy (90%)
Inst. Holders50 funds
Inst. Value$2.9B
Inst. Activity26 buys / 19 sells
Insider Activity1B / 22S
Insider Net $-$11.9M
SEC Reports12
Press Releases1
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·CIK 0001388658·Prev Close $112.67

Recent Activity

Jun 5, 2026 SEC
iRhythm Holdings disclosed a binding settlement agreement to resolve a securities class action for $45 million, with the
8-K — Impact 5/10
Jun 2, 2026 Insider
Shrishrimal Sumi sold 1,716 shares
EVP, Chief Risk Officer @ $108.19 ($185.7K)
May 29, 2026 Insider
Shrishrimal Sumi was granted 133 shares
EVP, Chief Risk Officer @ $96.82 ($12.9K)
May 29, 2026 Insider
Blackford Quentin S. was granted 178 shares
President and CEO @ $96.82 ($17.2K)
May 28, 2026 SEC
iRhythm Holdings held its 2026 Annual Meeting on May 27, 2026, with 89.69% of shares represented. Stockholders approved
8-K — Impact 2/10
May 12, 2026 SEC
Director Abhijit Talwalkar exercised 5,312 options at $10.71, simultaneously sold 940 shares on the open market at ~$116
CLUSTER — Impact 2/10
Inst.
RTW INVESTMENTS, LP — ADD
1,668,500 shares ($196.9M)
Inst.
FMR LLC — DOUBLED
1,361,919 shares ($160.7M)

Price Targets

$178.93 +57.4% upside Strong Buy
Current $113.65 Low $147.00 Median $177.50 High $255.00 14 analysts
$147.00 $255.00

Analyst Ratings

Strong Buy90% buy · 21 analysts
9Strong Buy
10Buy
2Hold
0Sell
0Strong Sell
Recent Analyst Actions
DateFirmActionRating
Jun 10, 2026 BTIG REITERATE Buy → Buy
Jun 1, 2026 Canaccord Genuity MAINTAIN Buy → Buy
May 18, 2026 B of A Securities MAINTAIN Buy → Buy
May 4, 2026 Citigroup MAINTAIN Buy → Buy
May 1, 2026 Canaccord Genuity MAINTAIN Buy → Buy

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $0.00 $-0.10 — $0.12 100% YoY 10
Next Q $0.09 $0.01 — $0.19 249% YoY 10
Current FY $0.12 ▼ -8.6% $-0.12 — $0.30 111% YoY 10
Next FY $1.05 ▲ +0.8% $0.76 — $1.51 800% YoY 10

Top Institutional Holders

FundValueMove
BlackRock, Inc.$323.6M
VANGUARD PORTFOLIO MANAGEMENT LLC$212.0M
RTW INVESTMENTS, LP$196.9MADD
Artisan Partners Limited Partnership$171.2MTRIM
VANGUARD CAPITAL MANAGEMENT LLC$170.6M

Recent Insider Trades

DateInsiderTypeValue
Jun 2, 2026Shrishrimal SumiSELL$185.7K
May 29, 2026Shrishrimal SumiA$12.9K
May 29, 2026Blackford QuentinA$17.2K
May 29, 2026Patterson ChadA$17.1K
May 29, 2026Turakhia MinangA$13.3K
50 institutional holders with $2.9B total value (24,431,025 shares) as of 2026-Q1. Top holders: BlackRock,, VANGUARD, RTW. Net buying activity: 26 institutions added/increased vs 19 reduced.

Top Institutional Holders — 2026-Q1

#FundSharesValue% of TrackedLast Move
1BlackRock, Inc.2,741,505$323.6M11.2%
2VANGUARD PORTFOLIO MANAGEMENT LLC1,796,372$212.0M7.4%
3RTW INVESTMENTS, LP1,668,500$196.9M6.8%ADD +41.2%
4Artisan Partners Limited Partnership1,450,907$171.2M5.9%TRIM -41.1%
5VANGUARD CAPITAL MANAGEMENT LLC1,445,710$170.6M5.9%
6FMR LLC1,361,919$160.7M5.6%DOUBLED +116.6%
7Holocene Advisors, LP1,248,658$147.4M5.1%ADD +82.7%
8STATE STREET CORP788,302$93.0M3.2%
9BNP Paribas Asset Management Holding S.A.762,062$89.9M3.1%ADD +30.7%
10FULLER & THALER ASSET MANAGEMENT, INC.674,698$79.6M2.8%
11BLAIR WILLIAM & CO/IL628,385$74.2M2.6%
12Point72 Asset Management, L.P.599,405$70.7M2.5%DOUBLED +173.1%
13ARROWSTREET CAPITAL, LIMITED PARTNERSHIP582,879$68.8M2.4%
14D. E. Shaw & Co., Inc.554,266$65.4M2.3%
15Capital Research Global Investors509,590$60.1M2.1%TRIM -57.0%
16Allspring Global Investments Holdings, LLC467,113$55.2M1.9%
17BANK OF AMERICA CORP /DE/432,539$51.0M1.8%
18Polar Capital Holdings Plc421,612$49.8M1.7%ADD +36.8%
19MANUFACTURERS LIFE INSURANCE COMPANY, THE390,577$46.1M1.6%ADD +99.2%
20MACKENZIE FINANCIAL CORP371,475$43.8M1.5%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
RTW INVESTMENTS, LPADD1,181,9901,668,500+41.2%$196.9M2026-Q1
FMR LLCDOUBLED628,7661,361,919+116.6%$160.7M2026-Q1
Holocene Advisors, LPADD683,5681,248,658+82.7%$147.4M2026-Q1
BNP Paribas Asset Management Holding S.A.ADD583,014762,062+30.7%$89.9M2026-Q1
Point72 Asset Management, L.P.DOUBLED219,468599,405+173.1%$70.7M2026-Q1
Capital Research Global InvestorsTRIM1,184,746509,590-57.0%$60.1M2026-Q1
Polar Capital Holdings PlcADD308,100421,612+36.8%$49.8M2026-Q1
MANUFACTURERS LIFE INSURANCE COMPANY, THEADD196,075390,577+99.2%$46.1M2026-Q1
Invesco Ltd.TRIM498,385297,452-40.3%$35.1M2026-Q1
SCHRODER INVESTMENT MANAGEMENT GROUPADD162,053247,746+52.9%$28.3M2026-Q1
MORGAN STANLEYADD169,991237,799+39.9%$28.1M2026-Q1
AMERIPRISE FINANCIAL INCADD123,621236,786+91.5%$27.9M2026-Q1
BAMCO INC /NY/NEW183,900$21.7M2026-Q1
FEDERATED HERMES, INC.ADD106,407149,459+40.5%$17.6M2026-Q1
Trexquant Investment LPADD78,653111,311+41.5%$13.1M2026-Q1
WCM INVESTMENT MANAGEMENT, LLCADD73,292108,078+47.5%$12.3M2026-Q1
WELLINGTON MANAGEMENT GROUP LLPNEAR_EXIT408,25690,460-77.8%$10.7M2026-Q1
SILVERCREST ASSET MANAGEMENT GROUP LLCADD47,89861,681+28.8%$7.3M2026-Q1
CANADA PENSION PLAN INVESTMENT BOARDADD30,10058,800+95.3%$6.9M2026-Q1
RENAISSANCE TECHNOLOGIES LLCTRIM103,90053,800-48.2%$6.3M2026-Q1
AmundiADD33,41049,575+48.4%$5.9M2026-Q1
Verition Fund Management LLCADD19,60034,565+76.4%$4.1M2026-Q1
ENVESTNET ASSET MANAGEMENT INCADD23,20432,134+38.5%$3.8M2026-Q1
VICTORY CAPITAL MANAGEMENT INCTRIM43,21522,172-48.7%$2.6M2026-Q1
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.TRIM39,74721,238-46.6%$2.5M2026-Q1
18 unique insiders with 50 transactions. Net insider value: -$11.9M ($56.9K bought, $11.9M sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Jun 2, 2026Shrishrimal SumiEVP, Chief Risk OfficerSELL1,716$108.19$185.7K
May 29, 2026Shrishrimal SumiEVP, Chief Risk OfficerAWARD133$96.82$12.9K
May 29, 2026Blackford Quentin S.President and CEOAWARD178$96.82$17.2K
May 29, 2026Patterson ChadCHIEF COMM & PRODUCT OFFICERAWARD177$96.82$17.1K
May 29, 2026Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECHAWARD137$96.82$13.3K
May 27, 2026TALWALKAR ABHIJIT YDirectorAWARD1,573
May 27, 2026YOOR BRIAN BDirectorAWARD1,573
May 27, 2026OBOYLE KEVIN CDirectorAWARD1,573
May 27, 2026Ling KarenDirectorAWARD1,573
May 27, 2026MCGINNIS KAREN KDirectorAWARD1,573
May 27, 2026Bodaken Bruce G.DirectorAWARD1,573
May 27, 2026Bairey Merz Cathleen NoelDirectorAWARD1,573
May 11, 2026TALWALKAR ABHIJIT YDirectorBUY5,312$10.71$56.9K
May 11, 2026TALWALKAR ABHIJIT YDirectorSELL940$116.05$109.1K
May 11, 2026TALWALKAR ABHIJIT YDirectorEXERCISE5,312$10.71$56.9K
May 4, 2026Lawrence Brian LeeChief Technology OfficerSELL1,014$120.80$122.5K
Mar 16, 2026Smith MervinEVP Strategic Business OpsSELL2,585$114.30$295.5K
Mar 12, 2026Patten Jason HDirectorAWARD2,218
Mar 2, 2026Smith MervinEVP Strategic Business OpsSELL752$128.44$96.6K
Mar 2, 2026Wilson Daniel G.Chief Financial OfficerSELL755$128.44$97.0K
Mar 2, 2026Shrishrimal SumiEVP, Chief Risk OfficerSELL946$128.44$121.5K
Mar 2, 2026Patterson ChadCHIEF COMM & PRODUCT OFFICERSELL1,414$128.44$181.6K
Mar 2, 2026Blackford Quentin S.President and CEOSELL4,347$128.44$558.3K
Mar 2, 2026Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECHSELL1,487$128.45$191.0K
Mar 2, 2026Murphy Patrick MichaelCBO and CLOSELL2,028$128.44$260.5K
Mar 2, 2026Rosenbaum Marc WadeChief Accounting OfficerSELL399$128.45$51.3K
Feb 25, 2026Freeman Sean ClintonEVP, Strategy & Corp DevtAWARD7,525
Feb 25, 2026Rosenbaum Marc WadeChief Accounting OfficerSELL4,797$135.42$649.6K
Feb 25, 2026Wilson Daniel G.Chief Financial OfficerAWARD8,361
Feb 25, 2026Shrishrimal SumiEVP, Chief Risk OfficerAWARD5,518
Feb 25, 2026Patterson ChadCHIEF COMM & PRODUCT OFFICERAWARD10,870
Feb 25, 2026Murphy Patrick MichaelCBO and CLOAWARD7,024
Feb 25, 2026Rosenbaum Marc WadeChief Accounting OfficerAWARD2,508
Feb 25, 2026Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECHAWARD10,034
Feb 25, 2026Murphy Patrick MichaelCBO and CLOSELL7,805$135.42$1.1M
Feb 25, 2026Blackford Quentin S.President and CEOAWARD31,842
Feb 25, 2026Blackford Quentin S.President and CEOSELL25,540$135.42$3.5M
Feb 25, 2026Smith MervinEVP Strategic Business OpsSELL4,041$135.42$547.2K
Feb 25, 2026Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECHSELL7,804$135.42$1.1M
Feb 25, 2026Wilson Daniel G.Chief Financial OfficerSELL5,188$135.42$702.6K
Feb 25, 2026Shrishrimal SumiEVP, Chief Risk OfficerSELL6,217$135.42$841.9K
Feb 25, 2026Patterson ChadCHIEF COMM & PRODUCT OFFICERSELL8,967$135.42$1.2M
Feb 25, 2026Smith MervinEVP Strategic Business OpsAWARD6,689
Feb 24, 2026Smith MervinEVP Strategic Business OpsSELL732$140.91$103.1K
Feb 24, 2026Rosenbaum Marc WadeChief Accounting OfficerAWARD9,210
Feb 24, 2026Patterson ChadCHIEF COMM & PRODUCT OFFICERAWARD17,318
Feb 24, 2026Blackford Quentin S.President and CEOAWARD46,687
Feb 24, 2026Smith MervinEVP Strategic Business OpsAWARD9,210
Feb 24, 2026Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECHAWARD15,060
Feb 24, 2026Rosenbaum Marc WadeChief Accounting OfficerSELL280$140.91$39.5K
12 SEC filing reports analyzed. Sentiment: 2 bullish, 4 bearish, 0 mixed, 6 neutral. Avg impact: 4.6/10.
BULLISH 8-K 5/10
iRhythm Holdings disclosed a binding settlement agreement to resolve a securities class action for $
Jun 5, 2026
NEUTRAL 8-K 2/10
iRhythm Holdings held its 2026 Annual Meeting on May 27, 2026, with 89.69% of shares represented. St
May 28, 2026
NEUTRAL CLUSTER 2/10
Director Abhijit Talwalkar exercised 5,312 options at $10.71, simultaneously sold 940 shares on the
May 12, 2026
NEUTRAL 144 2/10
Director Abhijit Y. Talwalkar filed a Form 144 notice of intent to sell 5,312 shares of iRhythm Hold
May 11, 2026
BULLISH PRESS-RELEASE 8/10
iRhythm reported Q1 2026 revenue of $199.4M (+25.7% YoY) and GAAP EPS of -$0.43, beating consensus e
Apr 30, 2026
NEUTRAL DEFA14A 2/10
iRhythm Holdings, Inc. has filed a definitive proxy statement (DEFA14A) for its upcoming shareholder
Apr 17, 2026
BEARISH CLUSTER 7/10
Multiple C-suite executives at iRhythm sold shares in a concentrated 7-day window, including CEO Que
Mar 3, 2026
BEARISH CLUSTER 7/10
Multiple C-suite executives at iRhythm (IRTC) sold shares in a concentrated 3-day window, including
Feb 27, 2026
BEARISH CLUSTER 7/10
Seven iRhythm executives, including the CEO and other C-suite leaders, sold a combined $7.4 million
Feb 26, 2026
BEARISH CLUSTER 7/10
iRhythm CEO Quentin Blackford sold $3.46M in shares just after being granted 46,687 non-cash shares,
Feb 26, 2026
NEUTRAL CLUSTER 3/10
Three insiders at iRhythm Technologies sold or exercised shares within a 7-day window, including two
Feb 26, 2026
NEUTRAL CLUSTER 3/10
Three insiders at iRhythm Technologies sold or exercised shares in the past week, including two open
Feb 26, 2026
Current analyst consensus: Strong Buy (90% buy). Based on 21 analysts: 9 strong buy, 10 buy, 2 hold, 0 sell, 0 strong sell.

Analyst Price Targets

$178.93 mean target +57.4% upside Strong Buy (1.27)
$147.00 Low $255.00 High
MetricValue
Current Price$113.65
Target Low$147.00
Target Mean$178.93
Target Median$177.50
Target High$255.00
# Analysts14
RecommendationStrong Buy (1.27)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$0.00 $-0.10 $0.12 100.2% +0.0% $0.2B 17.5% 10
Next Q
2026-09-30
$0.09 $0.01 $0.19 248.8% +0.0% $0.2B 15.0% 10
Current FY
2026-12-31
$0.12 $-0.12 $0.30 111.3% -8.6% 0↑ 1↓ $0.9B 17.9% 10
Next FY
2027-12-31
$1.05 $0.76 $1.51 800.2% +0.8% 9↑ 1↓ $1.0B 15.7% 10

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$0.001
7d ago$0.001
30d ago$0.001
60d ago$-0.096+0.096
90d ago$-0.096+0.096
11 analyst firms have rated this stock: 1 upgrades, 0 downgrades, 0 initiations.

Individual Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Jun 10, 2026 BTIG REITERATE Buy Buy
Jun 1, 2026 Canaccord Genuity MAINTAIN Buy Buy
May 18, 2026 B of A Securities MAINTAIN Buy Buy
May 4, 2026 Citigroup MAINTAIN Buy Buy
May 1, 2026 Canaccord Genuity MAINTAIN Buy Buy
May 1, 2026 JP Morgan MAINTAIN Overweight Overweight
May 1, 2026 Wells Fargo MAINTAIN Overweight Overweight
May 1, 2026 Evercore ISI Group MAINTAIN Outperform Outperform
May 1, 2026 Needham MAINTAIN Buy Buy
Apr 15, 2026 Truist Securities MAINTAIN Buy Buy
Apr 9, 2026 Goldman Sachs MAINTAIN Neutral Neutral
Apr 6, 2026 Evercore ISI Group MAINTAIN Outperform Outperform
Mar 11, 2026 Citigroup MAINTAIN Buy Buy
Feb 23, 2026 Truist Securities REITERATE Buy Buy
Feb 20, 2026 Canaccord Genuity MAINTAIN Buy Buy
Feb 20, 2026 JP Morgan MAINTAIN Overweight Overweight
Feb 20, 2026 Wells Fargo MAINTAIN Overweight Overweight
Feb 20, 2026 Baird MAINTAIN Outperform Outperform
Jan 13, 2026 Wells Fargo MAINTAIN Overweight Overweight
Jan 12, 2026 Needham REITERATE Buy Buy
Jan 5, 2026 Evercore ISI Group UPGRADE In-Line Outperform
Dec 18, 2025 Truist Securities MAINTAIN Buy Buy
Dec 16, 2025 Baird MAINTAIN Outperform Outperform

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 202691020090%
May 1, 202691020090%
Apr 1, 202691020090%
Mar 1, 202691120091%
Feb 1, 202691030086%
Jan 1, 202691030086%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 19, 2026
other
iRhythm Holdings to Participate in Upcoming Investor Conferences
<p align="left">SAN FRANCISCO, May 19, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LzoyZxhVbXTYzDGPIyAppvOZv2Dhyvzk
May 1, 2026
short_volume
Short Volume: IRTC — 58.7% short (0.3M / 0.5M)
Short: 302,938 | Exempt: 1 | TRF Vol: 515,850 | Short Ratio: 58.7% | Off-exchange volume (dark pool + OTC)
Apr 30, 2026
earnings
iRhythm Holdings Announces First Quarter 2026 Financial Results
<p>SAN FRANCISCO, April 30, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=4YB32D3BsI2ig3RhPntXd4gb_aVYWk6GcviX3ix60r4
Apr 30, 2026
earnings_calendar
IRTC Q1 2026 Earnings Scheduled — 2026-04-30
Apr 27, 2026
fda
New Data Presented at HRS 2026 Show Short-Term Holter Monitoring Misses a Large Proportion of AF Recurrence Post-Ablation and Clinically Significant Arrhythmias in Pregnancy
Data presented at HRS 2026 reinforce the clinical value of iRhythm's Zio ambulatory ECG devices and service across diverse patient populations
Apr 16, 2026
earnings
iRhythm Holdings to Report First Quarter 2026 Financial Results on April 30, 2026
<p align="left">SAN FRANCISCO, April 16, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=WZia_TsPRyRia2JLWOzxWdz__lpcXP
Apr 1, 2026
short_interest
FTD: IRTC — 6,233 shares ($0.7M) failed to deliver
Settlement: 20260401, Price: $118.02, FTD Value: $735,618.66, IRHYTHM HLDGS INC COM
Mar 30, 2026
other
Data presented at ACC.26 further demonstrate the benefits of iRhythm’s Zio® ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform
Data presented at ACC.26 demonstrate a high prevalence of clinically actionable arrhythmias across CKM patient populations using Zio® ambulatory ECG
Mar 16, 2026
short_interest
FTD: IRTC — 14,131 shares ($1.6M) failed to deliver
Settlement: 20260316, Price: $113.00, FTD Value: $1,596,803, IRHYTHM HLDGS INC COM
Mar 12, 2026
other
iRhythm Holdings Appoints Jason Patten to its Board of Directors
<p><img alt="Jason Patten" height="220" src="https://ml.globenewswire.com/Resource/Download/4bcdbc81-4743-4f25-bb38-959098796398/jason-patten.jpg" wid
Mar 3, 2026
short_interest
FTD: IRTC — 4,809 shares ($0.6M) failed to deliver
Settlement: 20260303, Price: $128.46, FTD Value: $617,764.14, IRHYTHM HLDGS INC COM
Mar 2, 2026
short_interest
FTD: IRTC — 41,911 shares ($5.6M) failed to deliver
Settlement: 20260302, Price: $133.75, FTD Value: $5,605,596.25, IRHYTHM HLDGS INC COM